OMRF has entered a license agreement with Shanghai RAAS Blood Products for development of novel hemophilia treatment.
The grants cover a range of areas, including colitis and colon cancer, sepsis, genomic tools, and outreach strategies for clinical trials.
Lupu’s findings were published in the Proceedings of the National Academy of Sciences.
Awards “a testament to the quality of research in Oklahoma”
Understanding anthrax could lead to therapies for other deadly medical threats.
Researchers found the answer to a long-standing medical mystery in platelets.